Showing results (11-20 of 161) with videos related to
Sort By:
Pageof 17
Medicine|July 27, 2023
The pluripotential evolution and journey of Botox (onabotulinumtoxinA)Mitchell F Brin, Andrew BlitzerToxicon : Official Journal of the International Society on Toxinology|April 26, 2025
Botulinum neurotoxin type DC (BoNT/DC) cleavage of VAMP3 reduces melanin production in melanocytesShiazah Malik, Linh Le, Raymond E Boissy, et al.Headache|December 3, 2016
Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic TherapiesSheena K Aurora, Mitchell F BrinBiologics : Targets & Therapy|October 23, 2014
Botulinum toxin type A products are not interchangeable: a review of the evidenceMitchell F Brin, Charmaine James, John MaltmanMedicine|July 27, 2023
Treatment of cervical dystonia with Botox (onabotulinumtoxinA): Development, insights, and impactJoseph Jankovic, Joseph Tsui, Mitchell F BrinToxins|October 26, 2022
Botulinum Neurotoxin Type A Directly Affects Sebocytes and Modulates Oleic Acid-Induced LipogenesisKaren Brami-Cherrier, Alex Chernavsky, Hui You, et al.Medicine|July 27, 2023
Early development history of Botox (onabotulinumtoxinA)Alan B Scott, Dennis Honeychurch, Mitchell F BrinMedicine|July 27, 2023
Treatment of strabismus and blepharospasm with Botox (onabotulinumtoxinA): Development, insights, and impactAlan B Scott, Stanley Fahn, Mitchell F BrinJournal of Cell Science|June 22, 2002
Ca2+-induced changes in SNAREs and synaptotagmin I correlate with triggered exocytosis from chromaffin cells: insights gleaned into the signal transduction using trypsin and botulinum toxinsGary W Lawrence, J Oliver DollyProceedings of the National Academy of Sciences of the United States of America|November 15, 2011
Dendritic SNAREs add a new twist to the old neuron theorySaak V Ovsepian, J Oliver DollyPageof 17